Home

NTCA Provider Guidance on Using the Isoniazid/Rifapentine Regimen to Treat Latent Tuberculosis Infection (LTBI)Donate through AmazonSmileDecember 2018 NTCA All Member Call

About the National Tuberculosis Controllers Association

The NTCA was created in 1995 to bring together the leaders of tuberculosis control programs in all states and territories, as well as many counties and city health departments that organize their own TB control activities. Learn more…

  • Home page noteworthy

    Noteworthy

    Call for Papers

    October 31 — CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention’s Office of Health Equity called for papers for a thematic journal supplement, “Policy Approaches to Reduce the Morbidity, Mortality, and Incidence of HIV, Viral Hepatitis, Sexually Transmitted Diseases, and Tuberculosis,” which will be published by Public Health Reports (PHR). Abstracts are due January 4, 2019. For more details, see the notice.

    Call to Scale Up Use of LAM Test

    October 25 — Activists at the Union Conference called for immediately scaling up the use of TB LAM testing to end the unacceptable rates of death caused by TB in people living with HIV. TB remains the leading killer of people living with HIV and TB. The LAM diagnostic test is simple, inexpensive and life-saving test for detecting TB in people with advanced HIV who are at highest risk of dying from TB.

    Nursing Guide to Managing Side Effects to Drug-resistant TB Treatment

    October 24 — The Curry International TB Center and the International Council of Nurses announced the release of the Nursing Guide for Managing Side Effects to Drug-resistant TB Treatment.